Given that the primary hallmark of human osteosarcoma is excessive mineralized type I collagen deposition, a reduction in its production by the targeted blockade of Endo180 function may also contribute to limiting the bony deposits made by osteosarcoma cells and osteoblasts associated within the tumour mass and adjacent bone stroma 17. Here, MRC2 is linked to osteosarcoma.